Respiratory viruses predisposing to bacterial infections: Role of neuraminidase

Pediatric Infectious Disease Journal

Volumn 23, Issue 1 SUPPL., 2004, Pages

  Peltola, Ville T ^a   McCullers, Jonathan A ^a   Fink, Robert J ^b   Fedson, David S ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

Influenza; Neuraminidase; Parainfluenza; Pneumococcus; Respiratory syncytial virus; Viral bacterial synergism

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; INFLUENZA VACCINE; SIALIC ACID; SIALIDASE;

ANIMAL; ANIMAL MODEL; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; COMORBIDITY; COMPARATIVE STUDY; CONFERENCE PAPER; DISEASE MODEL; DISEASE PREDISPOSITION; DOG; EPIDEMIOLOGY; FEMALE; GENE EXPRESSION; HOST CELL; IN VITRO STUDY; INFLUENZA VACCINATION; INFLUENZA VIRUS; ISOLATION AND PURIFICATION; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS EPITHELIUM; MALE; METABOLISM; MOUSE; NONHUMAN; ORTHOMYXOVIRUS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; SUPERINFECTION; TREATMENT OUTCOME; UPREGULATION; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 0842284589     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000108197.81270.35     Document Type: Conference Paper

References (103)

1. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell, 1998:3-18.
2. Muir R, Wilson GH. Influenza and its complications. Br Med J 1919;1:3-5.
3. Wilson CB, Steer P. Bacteriological and pathological observations on influenza as seen in France during 1918. Br Med J 1919;634-5.
4. Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999;17(Suppl 1):S3-10.
5. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000;342:225-31.
6. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000;181:831-7.
7. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
8. Counihan ME, Shay DK, Holman RC, Lowther SA, Anderson LJ. Human parainfluenza virus-associated hospitalizations among children less than five years of age in the United States. Pediatr Infect Dis J 2001;20:646-53.
9. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-6.
10. Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Field's virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1487-531.
11. Lamb RA, Krug RM. Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Field's virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1305-40.
12. McCullers JA, Bartmess KC. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis 2003;187:1000-9.
13. Office of Statistics and Programming NC. Deaths and death rates for the 10 leading causes of death in specified age groups, by race and sex: United States, 1997. Natl Vital Stat Rep 1999;47:27-37.
14. Ostroff SM, Leduc JW. Global epidemiology of infectious diseases. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practices of infectious diseases. 5th ed. New York: Churchill Livingstone, 2000:167-9.
15. Fedson DS, Anthony J, Scott G. The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine 1999;17(Suppl 1)S11-18.
16. Simonsen L. Influenza-related morbidity and mortality among children in developed and developing countries. In: Osterhaus ADME, Cox N, Hampson AW, eds. Options for the control of influenza IV. Amsterdam: Elsevier, 2001:13-9.
17. Camara M, Mitchell TJ, Andrew PW, Boulnois GJ Streptococcus pneumoniae produces at least two distinct enzymes with neuraminidase activity: cloning and expression of a second neuraminidase gene in Escherichia coli. Infect Immun 1991;59:2856-8.
18. Berry AM, Lock RA, Paton JC. Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli. J Bacteriol 1996;178:4854-60.
19. Syrjanen RK, Kilpi TM, Kaijalainen TH, Herva EE, Takala AK. Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. J Infect Dis 2001;184:451-9.
20. Brimblecombe FSW, Cruickshank R, Masters PL, Reid DD, Stewart GT. Family studies of respiratory infections. Br Med J 1958;1:119-28.
21. Faden H, Waz MJ, Bernstein JM, et al. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol 1991;100:612-15.
22. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun 1995;63:1153-7.
23. Chonmaitree T, Howie VM, Truant AL. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 1986;77:698-702.
24. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev 2003;16:230-41.
25. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999;340:260-4.
26. Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306:1377-83.
27. Vesa S, Kleemola M, Blomqvist S, et al. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J 2001;20:574-81.
28. Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J 1989;8:94-9.
29. Koivunen P, Kontiokari T, Niemela M, Pokka T, Uhari M. Time to development of acute otitis media during an upper respiratory tract infection in children. Pediatr Infect Dis J 1999;18:303-5.
30. Heikkinen T. Temporal development of acute otitis media during upper respiratory tract infection. Pediatr Infect Dis J 1994;13:659-61.
31. Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994;330:25-30.
32. Kristo A, Uhari M, Luotonen J, et al. Paranasal sinus findings in children during respiratory infection evaluated with magnetic resonance imaging. Pediatrics 2003;111: e586-9.
33. Evans FO Jr, Sydnor JB, Moore WE, et al. Sinusitis of the maxillary antrum. N Engl J Med 1975;293:735-9.
34. Hamory BH, Sande MA, Sydnor A Jr, Seale DL, Gwaltney JM Jr Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979;139:197-202.
35. Gwaltney JM. Sinusitis. In: Mandell GL, Bennett JE, Dolin R. eds. Mandell, Douglas and Bennett's principles and practices of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:585-90.
36. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000;19:293-8.
37. Korppi M, Leinonen M, Makela PH, Launiala K. Bacterial involvement in parainfluenza virus infection in children. Scand J Infect Dis 1990;22:307-12.
38. Taubenberger JK, Reid AH, Janczewski TA, Fanning TG. Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus. Philos Trans R Soc Lond B Biol Sci 2001;356:1829-39.
39. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. London: Blackwell, 1998:222-3.
40. Hers JFP, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs of fatal Asian influenza. Lancet 1958;2:1164-5.
41. Oswald NC, Shooter RA, Curwen MP. Pneumonia complicating Asian influenza. Br Med J 1958;2:1305-11.
42. Sharrar RG. National influenza experience in the USA, 1968-69. Bull World Health Organ 1969;41:361-6.
43. O'Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000;30:784-9.
44. Klimov A, Simonsen L, Fukuda K, Cox N. Surveillance and impact of influenza in the United States. Vaccine 1999;17(Suppl 1):S42-6.
45. Wright PF, Thompson J, Karzon DT. Differing virulence of H1N1 and H3N2 influenza strains. Am J Epidemiol 1980;112:814-9.
46. Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 1991;145:445-8.
47. Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med 1995;149:1113-7.
48. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 1998;338:1405-12.
49. Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis 2002;35:168-74.
50. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-95.
51. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
52. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003;361:2189-95.
53. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76.
54. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
55. Fedson DS, Wajda A, Nicol JP, et al. Clinical effectiveness of influenza vaccination in Manitoba. JAMA 1993;270:1956-61.
56. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001;184:665-70.
57. Christenson B, Lundbergh P, Hedlund J, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001;357:1008-11.
58. Hedlund J, Christenson B, Lundbergh P, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine 2003;21:3906-11.
59. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003;348:1747-55.
60. Hayden FG, Osterhaus AD, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections: GG167 Influenza Study Group. N Engl J Med 1997;337:874-80.
61. Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.
62. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J 2001;20:127-33.
63. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial: US Oral Neuraminidase Study Group. JAMA 2000;283:1016-24.
64. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 1998;352:1877-81.
65. Simoes EA, Groothuis JR, Tristram DA, et al. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr 1996;129:214-9.
66. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
67. Sanford BA, Shelokov A, Ramsay MA. Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection. J Infect Dis 1978;137:176-81.
68. Davison VE, Sanford BA. Adherence of Staphylococcus aureus to influenza A virus-infected Madin-Darby canine kidney cell cultures. Infect Immun 1981;32:118-26.
69. Selinger DS, Reed WP, McLaren LC. Model for studying bacterial adherence to epithelial cells infected with viruses. Infect Immun 1981;32:941-4.
70. Saadi AT, Blackwell CC, Raza MW, et al. Factors enhancing adherence of toxigenic Staphylococcus aureus to epithelial cells and their possible role in sudden infant death syndrome. Epidemiol Infect 1993;110:507-17.
71. Saadi AT, Blackwell CC, Essery SD, et al. Developmental and environmental factors that enhance binding of Bordetella pertussis to human epithelial cells in relation to sudden infant death syndrome (SIDS). FEMS Immunol Med Microbiol 1996;16:51-9.
72. Hakansson A, Kidd A, Wadell G, Sabharwal H, Svanborg C. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect Immun 1994;62:2707-14.
73. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995;377:435-8.
74. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002;186:341-50.
75. Gubareva LV, Nedyalkova MS, Novikov DV, et al. A release-competent influenza A virus mutant lacking the coding capacity for the neuraminidase active site. J Gen Virol 2002;83:2683-92.
76. Giebink GS. Otitis media: the chinchilla model. Microb Drug Resist 1999;5:57-72.
77. Giebink GS, Berzins IK, Marker SC, Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun 1980;30:445-50.
78. Tong HH, Fisher LM, Kosunick GM, DeMaria TF. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann Otol Rhinol Laryngol 2000;109:1021-7.
79. Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun 1983;41:913-20.
80. Harford CG, Smith MR, Wood WB. Sulfonamide chemotherapy of combined infection with influenza virus and bacteria. J Exp Med 1946;83:505-18.
81. Harford CG, Leidler V, Hara M. Effect of the lesion due to influenza virus on the resistance of mice to inhaled pneumococci. J Exp Med 1949;89:53-67.
82. Jones WT, Menna JH, Wennerstrom DE. Lethal synergism induced in mice by influenza type A virus and type Ia group B streptococci. Infect Immun 1983;41:618-23.
83. Okamoto S, Kawabata S, Nakagawa I, et al. Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol 2003;77:4104-12.
84. Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986;134:1040-4.
85. LeVine AM, Koeningsknecht V, Stark JM. Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001;94:173-86.
86. McCullers JA, Webster RG. A mouse model of dual infection with influenza virus and Streptococcus pneumoniae. In: Osterhaus ADME, Cox N, Hampson AW, eds. Options for the control of influenza IV. Amsterdam: Elsevier, 2001:601-7.
87. Giebink GS, Ripley ML, Wright PF. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann Otol Rhinol Laryngol 1987;96:199-206.
88. de Bentzmann S, Plotkowski C, Puchelle E. Receptors in the Pseudomonas aeruginosa adherence to injured and repairing airway epithelium. Am J Respir Crit Care Med 1996;154:S155-62.
89. Hartshorn KL, Liou LS, White MR, et al. Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol 1995;154:3952-60.
90. Engelich G, White M, Hartshorn KL. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol 2001;69:50-6.
91. Abramson JS, Giebink GS, Mills EL, Quie PG. Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J Infect Dis 1981;143:836-45.
92. Nickerson CL, Jakab GJ. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infect Immun 1990;58:2809-14.
93. Kleinerman ES, Daniels CA, Polisson RP, Snyderman R. Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice. Am J Pathol 1976;85:373-82.
94. Kleinerman ES, Snyderman R, Daniels CA. Depressed monocyte chemotaxis during acute influenza infection. Lancet 1975;2:1063-6.
95. M1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium. Microb Pathog 1999;26:111-19.
96. LaMarco KL, Diven WF, Glew RH. Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase. Ann Otol Rhinol Laryngol 1986;95:304-8.
97. Linder TE, Lim DJ, DeMaria TF. Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Microb Pathog 1992;13:293-303.
98. Tong HH, James M, Grants I, et al. Comparison of structural changes of cell surface carbohydrates in the Eustachian tube epithelium of chinchillas infected with a Streptococcus pneumoniae neuraminidase-deficient mutant or its isogenic parent strain. Microb Pathog 2001;31:309-17.
99. Tong HH, Grants I, Liu X, DeMaria TF. Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection. Infect Immun 2002;70:4292-301.
100. Wagner R, Wolff T, Herwig A, Pleschka S, Klenk HD. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol 2000;74:6316-23.
101. Kobasa D, Wells K, Kawaoka Y. Amino acids responsible for the absolute sialidase activity of the influenza A virus neuraminidase: relationship to growth in the duck intestine. J Virol 2001;75:11773-80.
102. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 2000;97:6108-13.
103. Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 2000;7:1068-74.